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Abstract
Background: Nutritional rickets is a growing global public health concern despite 
existing prevention programmes and health policies. We aimed to compare infant and 
childhood vitamin D supplementation policies, implementation strategies and practices 
across Europe and explore factors influencing adherence.
Methods: European Society for Paediatric Endocrinology Bone and Growth Plate 
Working Group members and other specialists completed a questionnaire on country-
specific vitamin D supplementation policy and child health care programmes, 
socioeconomic factors, policy implementation strategies and adherence. Factors 
influencing adherence were assessed using Kendall’s tau-b correlation coefficient.
Results: Responses were received from 29 of 30 European countries (97%). Ninety-six 
per cent had national policies for infant vitamin D supplementation. Supplements are 
commenced on day 1–5 in 48% (14/29) of countries, day 6–21 in 48% (14/29); only the 
UK (1/29) starts supplements at 6 months. Duration of supplementation varied widely 
(6 months to lifelong in at-risk populations). Good (≥80% of infants), moderate  
(50–79%) and low adherence (<50%) to supplements was reported by 59% (17/29), 31% 
(9/29) and 10% (3/29) of countries, respectively. UK reported lowest adherence (5–20%). 
Factors significantly associated with good adherence were universal supplementation 
independent of feeding mode (P = 0.007), providing information at neonatal unit 
(NNU) discharge (P = 0.02), financial family support (P = 0.005); monitoring adherence at 
surveillance visits (P = 0.001) and the total number of factors adopted (P < 0.001).
Conclusions: Good adherence to supplementation is a multi-task operation that works 
best when parents are informed at birth, all babies are supplemented, and adherence 
monitoring is incorporated into child health surveillance visits. Implementation strategies 
matter for delivering efficient prevention policies.
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Introduction
Vitamin D deficiency and its complications such as 
osteomalacia, rickets, hypocalcaemic seizures, dilated 
cardiomyopathy and skeletal myopathy are a growing 
concern worldwide in high-, medium- and low-
income countries regardless of the geographic location 
(1, 2, 3). If left untreated, long-term morbidity includes 
leg deformities, muscle weakness, falls and fractures, 
disability, unemployment and early death, such as from 
cardiomyopathy or obstructed labour. The cause and 
effect relationship between vitamin D and bone health 
is well established (4). Vitamin D supplementation of 
infants and pregnant mothers are practised in many 
countries to prevent rickets. The recent global consensus 
on the prevention of rickets recommends vitamin D 
supplementation not only during infancy and pregnancy 
but also for all ethnic risk groups (i.e. people with dark 
skin) especially those living at high latitude including all 
European countries (2, 5). In the wake of the European 
refugee crisis of 2015–2016, and the resulting longer term 
population demographic changes, Europe requires robust 
prevention programmes to protect the most vulnerable 
(6). However, there appears to be wide variation in the 
success of such vitamin D supplementation policies 
across Europe even for the existing population. We aimed 
to explore the differences in vitamin D policies and the 
factors relating to policy implementation that influence 
adherence rates.
Methods
A questionnaire with 20 questions was designed pertaining 
to the content of vitamin D supplementation policies, 
practices, infant health care and socioeconomic factors 
and policy implementation strategies. The questions were 
based on expert opinion (from paediatric endocrinology 
and public health) of factors that were perceived to 
influence adherence to infant vitamin D supplementation. 
The questions entailed:
 • presence of a national policy and whether vitamin D 
supplementation was dependent on the mode of feeding;
 • time of commencement and duration of 
supplementation;
 • presence of a recommended number of child health 
surveillance visits, professionals providing care and 
prescribing vitamin D supplements;
 • provision of financial family support and child care 
benefits by the government and whether supplements 
were free or paid for by the public;
 • whether adherence to supplementation is 
systematically monitored at child health surveillance 
visits and measured as part of national statistics. In 
the absence of national statistics, experts were asked 
to provide adherence rates for the first year of life from 
local audits or estimates, and details on adherence 
problems in certain subgroups of the population;
 • estimated average duration of breast feeding and time 
of weaning;
 • report of national policies on food fortification with 
vitamin D.
The questionnaire was sent to members of the European 
Society of Paediatric Endocrinology (ESPE) Bone and 
Growth Plate Working Group in May 2014, which included 
representatives from Turkey, Israel and Russia. Additional 
effort was made, via various contacts and sources, to reach 
out to public health professionals and experts in the field in 
other European countries. Contacts were established with 
30 countries and all except Iceland (97%) responded. For 
countries with two respondents, responses to dichotomous 
variables (yes/no) were only included if they were 
consistent. For countries with more than 2 respondents, 
the response of the majority was considered in the final 
analysis, when there was inconsistency in response. When 
adherence was provided as an estimated range, the highest 
quoted rate was used for statistical analysis.
Statistical analysis
Descriptive statistics was used, and countries were ranked 
by adherence rate for the first year of life, as the main 
outcome. Countries were grouped into good (≥80% of 
infants), moderate (50–79%) and low adherence (<50%). 
Adherence rate was cross tabulated with the total number 
of factors, and each individual factor, using Kendall’s 
tau-b correlation coefficient in SPSS statistical software, 
version 22.0. The effect of individual factors and the total 
number of factors (n = 11) on estimated country-specific 
adherence rates was compared.
Ethics
The study did not involve patients, and therefore did not 
require ethical approval or consent.
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Results
Forty responses were received electronically from 
representatives of 29 European countries. Two responses 
were received from Poland, Portugal, Netherlands and 
Serbia, three from Spain and six from Germany.
Characteristics of national policies
All countries except Italy (96%, 28/29) reported to have 
a national policy in place for vitamin D supplementation 
in infancy and childhood. Universal supplementation 
independent of the mode of feeding is recommended by 
79% of countries (23/29), whereas only breastfed infants 
are supplemented in Italy, Russia, Serbia, Greece and the 
UK (17%, 5/29).
Commencement and duration of supplementation
Vitamin D supplementation is commenced from 
day 1 to day 5 of life in 48% (14/29) and day 6 to 
day 21 in 48% (14/29) of European countries; the 
UK is the only country (1/29) where supplements 
are not recommended until 6  months of life. The 
recommended duration of supplementation varied 
widely, ranging from a minimum of 6  months to 
lifelong in at-risk population (Supplementary Table 1, 
see section on supplementary data given at the end of 
this article).
Professionals providing child health surveillance  
and prescribing vitamin supplements
Information to new parents on the rationale for vitamin 
D supplementation is provided before discharge from 
the neonatal/delivery unit in 86% of countries (24/28). 
Albania, Spain, Greece and the UK did not provide 
information to parents at discharge. Response from 
Portugal was not considered due to inconsistency.
All countries except Greece and Romania (93% of 
countries) have a recommended number of child health 
surveillance visits usually associated with immunisation 
schedules (‘red book’ or passport programmes). The 
various professionals providing child health surveillance 
are illustrated in Fig.  1A. Paediatricians provide child 
health surveillance solely (41%) or in partnership with 
other health care professionals (another 28%).
The responsibility of prescribing vitamin D is with the 
paediatrician in most countries, either solely (41%, 12/29) 
or in partnership with general practitioners (24%, 7/29), 
as illustrated in Fig. 1B.
Financial family support and child benefits
Patients pay for their prescription in 62% of countries 
(18/29), whereas governments provide free vitamin D 
supplies in 28% (8/29). In Italy and the UK, only families 
on low income support receive free supplements, and in 
Norway, only people from ethnic minorities.
Financial family support for children is provided 
by 86% of countries (25/29), varying from birth to a 
Figure 1
Professionals responsible for providing child health surveillance (A) and for prescribing vitamin D supplements (B). (A) Child health surveillance is 
provided by paediatricians in 41% of countries (12/29), followed by a combination of a paediatrician and a general practitioner (GP) in 21% (6/29). In 
Romania, Ireland, Hungary and Sweden, GPs provide health surveillance (14%, 4/29). Health visitors provide health surveillance in conjunction with: a 
Youth doctor in Netherlands, Paediatrician in Israel and GP in Denmark, Norway, Estonia and Finland (14%, 4/29). The UK is the only country where 
health surveillance is provided solely by health visitors. (B) Vitamin D supplements are prescribed by the paediatrician in majority of the countries 
followed by a combination of paediatrician and general practitioner (GP). In Denmark, vitamin D is prescribed by the health visitor, in Sweden by the 
‘well baby clinic’, in Israel by the ‘Mother and Child Health centre’, in Netherlands by the health visitor (HV) or ‘Mother and Child Health centre’. 
Vitamins are not prescribed but available to buy over the counter in Finland and Ireland. In Estonia and Norway, vitamin D is prescribed by GP or HV, 
whereas in Lithuania and Romania, it is prescribed by the GP.
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minimum of 26  weeks and a maximum of 18  years; 
however, only 28% of countries (7/25) – Albania, Austria, 
Bulgaria, France, Hungary, Italy and Macedonia – expect a 
100% attendance at child health surveillance visits to be 
eligible to claim these benefits.
Adherence and monitoring
All countries reported an adherence rate to infant vitamin 
D supplementation in the first year of life. Denmark, Turkey 
and Israel (11%) were the only countries that monitored 
adherence as part of national statistics. Germany, Ireland, 
Norway, Spain and UK provided evidence from regional 
studies. Estonia and Italy specified that the estimates were 
personal opinions and the remaining countries (19/29) did 
not specify the source of information and were assumed to 
be subjective estimates. Countries are ranked by adherence 
in Table 1 and depicted in Fig. 2. Good adherence (≥80% 
of infants) was reported by 59% of countries (17/29), 
moderate adherence (50–79%) by 31% (9/29) and low 
adherence (<50%) by 10% of countries (3/29). The UK 
had, by far, the lowest adherence rate (5–20%). Poor 
adherence in specific population subgroups was reported 
by 46% (13/28) of countries; however, subgroups were 
named only by 6 countries. Bulgaria, Norway, Romania, 
Serbia, Sweden and Switzerland specified compliance 
issues in Romani communities, ‘non-Westerners’, the 
rural population, immigrants, low socioeconomic groups 
and protestant sects, respectively.
A recommended number of child health surveillance visits 
for ongoing assessment of a child’s growth and development 
are practised in 93% (27/29) of European countries; however, 
only 67% (18/27) incorporate a monitoring check for 
adherence to vitamin D supplementation.
Infant feeding and food fortification
Breast feeding was estimated to be practised by >70% 
of mothers at 3 months and >50% at 6 months in 41% 
(12/29) of countries. Fewer women are breastfeeding in 
the other 59% of countries (17/29) – 10–70% of mothers 
at 3 months and 10–50% at 6 months.
Weaning is recommended at 6  months in 48% of 
countries (13/28) and 4 months in 25% of countries (7/28). 
The recommendations varied between 4  months and 
6 months in 25% of countries (7/28), mostly depending 
on the mode of feeding. Estonia recommended weaning 
at 4 months for vegetables and 6 months for meat.
Voluntary fortification of foods, other than infant 
formula, with vitamin D is practised in 55% of countries 
(16/29). No European country, except Israel currently 
mandates fortification. Fortified foods included milk, 
Figure 2
Adherence rates for infant vitamin D 
supplementation in the first year of life in 
Europe. In the absence of national statistics, the 
adherence rates given are subjective estimates by 
experts in the field. Good adherence (≥80% of 
infants supplemented) is indicated in green, 
moderate adherence (79–50%) in orange and low 
adherence (<50%) in red.
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margarine, yogurt, butter, dairy products, breakfast 
cereals, baby food and cookies.
Factors influencing adherence
Factors significantly associated with good adherence 
were universal supplementation independent of the 
mode of feeding (P = 0.007), providing information 
on supplementation at discharge from neonatal units 
(NNU) (P = 0.02), availability of financial family support 
(P = 0.005), monitoring of adherence to supplementation 
at child health surveillance visits (P = 0.001) and the total 
number of factors adopted (P < 0.001). Currently only 
55% (16/29) of countries incorporate all the 4 significant 
individual factors.
The proportion of countries adopting each significant 
factor in the 3 adherence groups is illustrated in Fig.  3. 
Countries with good adherence fulfilled 6–9 (median 8) 
of the 11 factors listed in Table 1, whereas countries with 
moderate and low adherence fulfilled between 3 and 7 
(median 6) and 2 and 5 (median 5) factors, respectively.
Factors not significantly associated with adherence 
rate included: Presence of national vitamin D 
supplementation policy (P = 0.4), commencement of 
supplements on day 1–5 (P = 1.0), free vitamin D supply 
by the government (P = 0.7), having a recommended 
number of child health surveillance visits (P = 0.07), 
mandatory attendance at surveillance visits to claim 
benefits (P = 0.1), national monitoring of adherence to 
supplementation (P = 0.8) and fortification of food with 
vitamin D (P = 1.0).
Discussion
This survey demonstrates that vitamin D supplementation 
policies, their implementation strategies and adherence 
vary widely across Europe. Our study shows that universal 
vitamin D supplementation independent of the mode 
of feeding, providing information on supplementation 
at discharge from NNU, monitoring of adherence at 
recommended child health surveillance visits and 
availability of financial family support are policy features 
and implementation strategies associated with good 
adherence. Adherence improved as the total number of 
factors adopted increased. Other factors, such as the cultural 
acceptance of supplements by different ethnic groups were 
reported, but could not be sufficiently explored.
Universal supplementation from early life (<21  days 
of life) is currently practised by 83% (24/29) of European 
countries. Vitamin D in infant formula is insufficient 
to protect infants from developing rickets (7). Hence, 
the global consensus on the prevention of rickets (2,  3) 
recommends 400 IU/day (10 µg) of vitamin D from birth to 
a minimum of 12 months of age, independent of the mode 
of feeding. This recommendation is also supported by our 
results, demonstrating that universal supplementation is 
associated with good adherence. Since vitamin D deficiency 
in the mother is always passed on to the infant, and serum 
half-life of 25-hydroxy vitamin D (25OHD) is only 2 weeks, 
prevention of rickets must include supplementation of 
pregnant women and infants from birth (2, 3). In the UK, 
supplements are not commenced until 6  months of age, 
which contributes to the rising incidence of rickets (8, 9), 
the morbidity from hypocalcaemic seizures (10), the deaths 
from hypocalcaemic cardiomyopathy (11) and undiagnosed 
rickets found post-mortem after unexplained sudden 
infant deaths reported in this country (12, 13). Notably, 
the vast majority of infants in these UK studies were from 
dark-skinned ethnic origin and fully breastfed. This study 
demonstrates that providing information at discharge 
from NNU and monitoring supplementation during health 
surveillance visits were associated with good adherence. 
Providing information and monitoring will automatically 
alert parents to the necessity of supplementation. Despite 
93% (27/29) of countries having a recommended number 
of child health surveillance visits, only 70% (19/27) of these 
countries monitor adherence to vitamin D supplementation 
programme at these visits. A survey from the United Kingdom 
has demonstrated that 85% of parents are unaware of the 
need for infant vitamin D supplementation (14) possibly due 
to lack of monitoring and lack of information at discharge 
from NNUs. Ultimately, for supplementation policies to 
Figure 3
Percentage of countries adopting each of the 4 independent significant 
factors, per adherence groups: good ≥80%, moderate 50–79% and low 
<50% of infants supplemented during the first year of life.
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work, health care professionals should be responsible for 
prescribing and monitoring, which is best done alongside 
recommended health surveillance visits and immunisation 
schedules and documented in the personal child health 
record (‘red book’ or passport). Similarly, supplementation 
during pregnancy can be easily monitored during routine 
visits using the antenatal health record or passports.
Financial family support significantly enhanced 
adherence and should therefore be incorporated into 
policies where feasible. Whilst strict implementation of a 
free, monitored vitamin D supplementation programme 
reduced the prevalence of rickets in Turkey (15), this study 
found that free, unmonitored vitamin D supply in isolation 
did not increase adherence, a finding supported by the 
low uptake of ‘Healthy Start’ free vitamins in the UK (16). 
Although promotion campaigns reportedly reduce the 
incidence of symptomatic vitamin D deficiency (17, 18), 
monitoring of supplementation at recommended health 
surveillance visits is a more sustainable and systematic way 
of ensuring awareness and adherence, according to this 
study. We also demonstrate that policy implementation 
is a multi-task operation. The more factors incorporated 
into policies, the greater the adherence.
High-risk populations (reduced sunlight exposure 
due to geographic location, covered clothing, dark skin, 
institutionalisation or hospitalisation and low socioeconomic 
status, reduced dietary calcium intake) should receive 
vitamin D supplementation beyond 12  months of age 
(2, 3), which is currently not universally practised in Europe. 
The incidence of rickets (5) and prevalence of symptomatic 
(19, 20, 21, 22) and simple vitamin D deficiency in Europe 
(23) is several folds higher in dark-skinned (resident or 
immigrant) ethnic subgroups compared to white children. 
Ethnic minority and immigrant children remain at 
increased risk of symptomatic vitamin D deficiency beyond 
the recommended age of supplementation as demonstrated 
in the UK (22, 24) and Denmark (25). These countries 
have changed their policies recommending lifelong 
supplementation in risk groups (25, 26). Similarly, the high 
prevalence of undiagnosed osteomalacia in adults related 
to vitamin D deficiency (27) highlights the importance of 
lifelong supplementation in the high-risk population. In 
light of the migration of dark-skinned people into Europe, 
there is an urgent need to review vitamin D supplementation 
policies and their implementation. Increased incidence of 
rickets in the immigrant population has been attributed 
not only to dark skin pigmentation, sun avoidance, 
covering the skin, but also to low dietary calcium intake 
(5). Of note, Norway and Sweden reported poor adherence 
in the immigrant population, and Romania and Serbia in 
those with low socioeconomic status, a known risk factor 
for poor adherence (28). Public health policies should 
therefore provide monitored, universal supplementation of 
all infants and these risk groups (dark-skinned, low socio 
economic status).
Food fortification of appropriate foods in conjunction 
with supplementation is most effective in preventing 
vitamin D deficiency by increasing population serum 
25OHD levels (29) as seen in Canada (30). The majority 
of European countries in this study follow voluntary 
fortification, as noted before (31), and countries tend 
to fortify milk and milk products. Limiting fortification 
to one food type may put certain groups at risk (32); 
therefore, it is essential to consider dietary habits of at-risk 
populations and target fortification accordingly (33).
Vitamin D status in children is poorly studied across 
the globe (34). Paucity of national data on adherence 
to prevention programmes, as highlighted here, creates 
challenges in designing and comparing prevention 
policies. Policy makers should consider a central European 
database, which holds information on health policies to 
enable information retrieval and update. The European 
micronutrient recommendations aligned  (EURRECA) 
project, established to address differences between 
countries in micronutrient recommendations, may be 
the right platform (35). Availability of accurate statistics 
on adherence will provide more robust evidence required 
to influence legislative authorities. In addition, investing 
in the prevention of vitamin D deficiency seems to have 
significant economic benefits (36, 37, 38).
The main study limitation was that information on 
adherence, feeding practices and non-adherent groups 
was mainly based on expert opinions. In addition, some 
inconsistent responses where noted when there was 
more than one respondent, which may reflect regional 
differences within countries. However, in the absence of 
national data, estimation by experts in the field was the 
next best alternative. Data from 22 European countries 
were missing because no contact could be established. 
Nonetheless, the largest western and central European 
countries are represented (55%), with different cultural 
and economic backgrounds.
Conclusion
The rise in nutritional rickets and low adherence to vitamin 
D supplementation are major public health concerns. 
Whilst national supplementation policies are in place 
across Europe, their implementation has been somewhat 
neglected. The results of this survey demonstrate that 
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relatively simple implementation strategies are associated 
with good adherence. Apart from providing information 
at discharge from NNU and universal supplementation 
of all babies, independent of the mode of feeding, the 
results of this survey specifically suggest that integrating 
the monitoring of adherence to supplementation into 
existing prevention programmes such as the child 
health surveillance visits (‘red book’, passports) increases 
adherence. Providing financial family support also 
enhanced adherence, suggesting that incentivising 
parents can improve child health. Improving adherence 
is a multi-task operation and one should adopt as many 
factors as feasible. Low and moderate adherence countries 
should consider adopting successful implementation 
strategies from high adherence European countries.
We call for more political effort to invest in 
implementation of efficient supplementation and 
fortification programmes to prevent symptomatic vitamin 
D deficiency, and thereby protect the most vulnerable 
members of society and minimise inequalities among 
socioeconomic groups and ethnic minorities.
Key points:
 • All infants, pregnant women and risk groups should 
receive preventative vitamin D supplements.
 • Supplementation policies are failing due to lack of 
clear implementation strategies and responsibilities.
 • 59% of European countries have good adherence to 
supplementation during the first year of life. Adherence 
to supplementation in the UK is lowest in Europe.
 • Monitoring adherence at child health surveillance 
visits, providing universal supplementation, 
information at birth and financial family support are 
factors significantly associated with good adherence.
 • A policy is only as good as its implementation strategy. 
Low and moderate adherence countries should consider 
adopting successful implementation strategies from 
high adherence European countries.
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